Index tracked: MSCI ACWI Leveraged 2x Select Index Daily (EUR)
TER
0.45%+ trans. 0.00%
Fund size
11 m EUR
Tracking difference
—not computable
🇮🇹 tax rate
—white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 28 Jul 2026 · costs from the KID as of 15 Aug 2026 · 73 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 15 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to provide a leveraged return of the MSCI ACWI Index (Underlying Index) by entering into swaps on a leveraged version of the Underlying Index, the MSCI ACWI Leveraged 2X Select Index Daily (index). It is expected that in the majority of circumstances, the rate of targeted leverage will be 200% (2X) but such targeted rate of leverage may vary between 150% (1.5X) and 200% (2X). The sub-portfolio manager for the fund is DWS Investments UK Limited. DWS Investments UK…
Rebalix · LU3386643970 · LU33866439701
RebalixLU3386643970 · LU3386643970 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: daily-reset leveraged/inverse product: yearly TD does not measure replication
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 2 Sept 2026 · 73 securities · top-10 weight = 37.7%
The live sheet, always up to date rebalix.com/en/etf/LU3386643970 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.